2018
Albert Bourla became Pfizer's chief operating officer in 2018 and its CEO in 2019.
“In 2018, he became chief operating officer and the following year, CEO.”
Topic
Albert Bourla is the chief executive of Pfizer, and this page collects what he and others said about him on podcasts including Lex Fridman, Freakonomics, M.D., Conversations with Mike Milken and STAT's The Readout Loud. The talks cover Pfizer's COVID vaccine effort, his career and his views on the industry.
Bourla told Lex Fridman that Pfizer committed about $2.3 billion to vaccine development at once instead of in stages. On Freakonomics, M.D., he said the company made its vaccine in nine months, compared with about eight years normally. He also said he was born in Thessaloniki, Greece, and spent about 17 of his nearly 30 years at Pfizer in animal health.
24 facts from 4 episodes, in date order. These are what speakers said on the shows, each linked to the moment it was said. They aren't independently verified.
2018
Albert Bourla became Pfizer's chief operating officer in 2018 and its CEO in 2019.
“In 2018, he became chief operating officer and the following year, CEO.”
2019
Lex Fridman said Albert Bourla had been at Pfizer for 28 years and became CEO in 2019.
“You've been at Pfizer for 28 years. Time flies when you're having fun. And you've become CEO in 2019.”
2020
Albert Bourla says Pfizer is one of the world's biggest suppliers of injectable medicines to hospitals, providing more than a billion units per year.
“We are one of the biggest providers of injectables to hospitals in the world. We are providing one point something billion units every year in the world.”
2020
Albert Bourla says the World Health Organization needs reform but countries should not leave it.
“I think WHO needs to be reformed, but we should never get out from WHO.”
2020
Albert Bourla said Pfizer committed about $2.3 billion to COVID vaccine development at once instead of in stages.
“Here, we put all together a little bit more than $2 billion, $2.3 billion.”
2020
Bourla says an independent committee told Pfizer executives that the Phase 3 trial was successful in an interim analysis.
“They told us the news that it was successful in an interim analysis.”
2020
Bourla says he was told the vaccine's efficacy in the interim analysis was 95.6.
“He said, so what is the efficacy? And then he told me 95.6.”
2020
Bourla says that if the vaccine had failed, Pfizer would have written off $2.5 billion.
“one thing it is, okay, we failed, I will have to write off $2.5 billion.”
2020
Bourla says he declined government funding because taking it would have required Pfizer's scientists to sit in numerous outside committees.
“by taking the money, I knew that my scientists will have to sit in numerous committees of people from wherever.”
2020
Bourla says Pfizer's vaccine team met twice a week, with him making the final decision at those meetings.
“So I said, it's you and me. So we will all be meeting twice a week, everybody who is needy for a decision.”
2020
Bourla says Pfizer made its COVID vaccine in nine months, compared with about eight years normally.
“if we were able to make a vaccine in nine months instead of eight years”
2021
Albert Bourla said Pfizer's employee vaccination rate rose from 90% to 96% after the company mandated vaccination.
“we were at 90 % vaccination rates when we said we are going to mandate it. And that took it up to 96%.”
2021
Albert Bourla said a false online story claimed his wife had died from vaccination, after an earlier false story claimed he was arrested by the FBI.
“A week later, the wife of the Pfizer CEO died.”
2023
Pfizer CEO Albert Bourla has said that provisions in the Inflation Reduction Act would remove copays for insured people, including for Covid vaccines.
“this is something that Pfizer CEO Albert Bourla has been out there on as well, actually saying that there are provisions in the Inflation Reduction Act that would take away any co-pays that insured people have”
Undated
Albert Bourla says he was born and raised in Thessaloniki, the second-largest city in Greece.
“I'm Greek by nationality, so I was born and raised in the second largest city of Greece. It's called Thessaloniki.”
Undated
Albert Bourla says he chose to become a veterinarian at age 18 because he loved animals and medicine.
“I became veterinarian. I was 18 when I made the choice, and I had an immense love for animals, and I liked medicine.”
Undated
Albert Bourla says he lived in nine cities across five countries during his career with Pfizer.
“I lived in nine different cities of five different countries with Pfizer.”
Undated
Albert Bourla says that about 17 of his nearly 30 years at Pfizer were spent in its animal health group rather than its pharmaceutical group.
“Most of my career in the 30 years, I'm having 30 years next year, 17 of them was in the animal health group, not in the pharma group.”
Undated
Bourla says mRNA technology allows work to be done in weeks that takes months with other vaccine technologies.
“With mRNA, you can move extremely fast. You can do in weeks things that you take months with the other technologies.”
Undated
Bourla says adenovirus-based vaccines are harder to boost because the body also makes antibodies against the adenovirus carrier, which can reduce effectiveness.
“It's not easy to boost with adenovirus because every time you are boosting, you are not creating only antibodies against the coronavirus, but also against the adenovirus, which is the carrier.”
Undated
Bourla says mRNA vaccine manufacturing is not a biological production and can be adapted by swapping in new variants.
“You don't have some bacteria that they are making your vaccine eventually. So you can really plug and play in the mRNA.”
Undated
Bapu Jena says Bourla told him Pfizer expected to submit data on a three-dose series for children under five, with a third dose appearing to add substantial protection.
“Pfizer expects to submit its data this month on the efficacy of a three-dose series for these kids, and that adding a third dose seemed to provide substantially more protection against COVID compared to just two doses.”
Undated
Bourla says the reputation of pharmaceutical companies before the pandemic was as bad as that of government in polls.
“The reputation of the pharmaceutical companies was as bad as the reputation of government in polls.”
Undated
Albert Bourla wrote a book titled Moonshot, Inside Pfizer's Nine-Month Race to Make the Impossible Possible.
“And check out his book, Moonshot, Inside Pfizer's Nine-Month Race to Make the Impossible Possible.”
Episodes